PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients out of options
Disease control Recruiting nowThis early-stage study is testing a new oral medication called HQP1351 for patients with chronic myeloid leukemia (CML) or a type of acute lymphoblastic leukemia (Ph+ ALL) that has stopped responding to or cannot tolerate standard treatments. The main goals are to find a safe and…
Matched conditions: PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New CAR-T cell strategy aims to control tough leukemia with less chemo
Disease control Recruiting nowThis study is testing a new treatment plan for adults newly diagnosed with a specific, aggressive type of blood cancer called Philadelphia-positive acute lymphoblastic leukemia. The plan uses a combination of targeted pills, a short course of chemotherapy, and a one-time infusion…
Matched conditions: PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC